In 2023, the Total Number of 10% Top-Cited Scientific Publications in Drug Discovery in the UK stood at 25.42. From 2024, the forecasts indicate a steady decline: 24.89 in 2024, 24.36 in 2025, 23.83 in 2026, 23.31 in 2027, and 22.78 in 2028. This represents a year-on-year decrease, with the compound annual growth rate (CAGR) over this period suggesting a consistent reduction.
Future trends to watch for include the impact of Brexit on research funding, collaborations with European institutions, and legislative changes affecting scientific research. Additionally, advancements in AI and biotechnology could influence publication volumes and citation rates.
